PureTech Ventures

General contacts
Investor type

VC

Founded

2001

AUM

-

Location

Boston, Massachusetts, United States

Investment Ticket

$10-50 m

Investment Stage

Pre-seed Seed Series A Series B Late Stage (Series C+)

Region of investment

North America
Investor profile last updated: 13 August, 2026

Profile

PureTech Ventures is a venture capital firm based in Boston, focusing on life sciences and health technology. Founded as a part of PureTech Health, the firm is led by CEO Robert Lyne, who has a background in UK-listed life science innovation. The team has extensive experience in research and development, having supported numerous regulatory approvals and strategic transactions. PureTech Ventures is characterized by its strong R&D engine and collaborative approach, partnering with scientific experts to co-invent and advance novel intellectual property.

The firm invests in various sectors within life sciences, with a focus on biotechnology and medical devices. They typically target companies at various stages of development, from early to late stage, though specifics on check sizes are not publicly detailed. PureTech Ventures collaborates internationally but is primarily concentrated in North America. As a component of PureTech Health, the firm benefits from extensive research capabilities and financial backing.

Notable portfolio companies include Celea Therapeutics, known for its innovative approaches to treating idiopathic pulmonary fibrosis. Other investments reflect a similar focus on transformative healthcare solutions, underscoring PureTech Ventures' strategic emphasis on high-impact technologies.

Industry

HealthTech Life Sciences Biotechnology Healthcare Services Medical Devices Pharmaceuticals

Contacts

Name
Title
Email
Social Networks
avatar
Robert Lyne Chief Executive Officer
Chief Executive Officer
r•••@•••
LinkedIn
avatar
Eric Elenko, PhD Co-founder & President
Co-founder & President
e•••@•••
Upgrade to see contacts
avatar
Ulk5IHEMzW6Tqhe3 Ulk5IHEMzW6Tqhe3
Ulk5IHEMzW6Tqhe3
[email protected]
linkedin twitter
avatar
Ulk5IHEMzW6Tqhe3 Ulk5IHEMzW6Tqhe3
Ulk5IHEMzW6Tqhe3
[email protected]
linkedin twitter
avatar
Ulk5IHEMzW6Tqhe3 Ulk5IHEMzW6Tqhe3
Ulk5IHEMzW6Tqhe3
[email protected]
linkedin twitter
Investment-team contacts for PureTech Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about PureTech Ventures

PureTech Ventures is a venture capital firm. It backs companies at Pre-seed, Seed, Series A, Series B and Late Stage (Series C+), writing tickets of $10-50 m.
PureTech Ventures is located in Boston, Massachusetts, United States.
PureTech Ventures was founded in 2001.
PureTech Ventures invests in companies and startups in HealthTech, Life Sciences, Biotechnology, Healthcare Services, Medical Devices, Pharmaceuticals.
PureTech Ventures invests in companies and startups in North America.
PureTech Ventures invests in companies and startups at Pre-seed, Seed, Series A, Series B, Late Stage (Series C+).
PureTech Ventures usually invests $10-50 m on average.
PureTech Ventures can be reached through its website puretechhealth.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for PureTech Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query PureTech Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 13 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.